Global Pen Needles Market to Reach USD 11.8 Billion by 2033, Supported by the Increasing Prevalence of Lifestyle Diseases

November 21, 2024 | Healthcare

According to the latest report by IMARC Group, titled “Pen Needles Market Report by Type (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormones), Mode of Purchase (Retail, Non-Retail), End User (Hospitals and Clinics, Home Healthcare, and Others), and Region 2025-2033,” the global pen needles market reached a value of USD 4.2 Billion in 2024. Pen needles refer to hollow and disposable needles that are fitted in pen injections for injecting a medicine in subcutaneous tissues of the body. They are largely used in diabetes medication pens. As compared to conventional alternatives, pen needles are cost-effective and are designed for the easy, more accurate and convenient dosage with minimal pain. The use of these needles eliminates the need for pushing through a rubber vial stopper. Pen needles are manufactured in varying lengths, which include 5mm, 12mm, 4mm, and 10mm. The components of a pen needle include a cylindrical posted hub, an inner shield with tactile ridges, and an outer cover with attachment grips.

Global Pen Needles Market Trends:

A significant rise in the prevalence of cardiovascular diseases and diabetes, particularly Type 2, is primarily driving the growth of the global pen needles market. Moreover, during the coronavirus (COVID-19) pandemic, patients took several measures to manage and treat their symptoms and existing ailments at home, which is inflating the sales of pen needles across the globe. Other than this, governments and non-governmental organizations (NGOs) have been undertaking several initiatives to spread awareness and put a curb to the reuse of needles, which is further contributing to the growth of the market. Moreover, leading players have been making investments in the research and development (R&D) activities to introduce more effective product variants. This is creating a positive outlook for the market. Looking forward, the market is projected to reach USD 11.8 Billion by 2033, growing at a CAGR of 12.2% during 2025-2033.

Market Summary:

  • On the basis of the type, the market has been bifurcated into standard and safety pen needles.
  • Based on the needle length, the market has been segmented into 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm.
  • On the basis of the therapy, the market has been segregated into insulin, GLP-1, and growth hormones.
  • Based on the mode of purchase, the market has been divided into retail and non-retail.
  • According to the end user, the market has been categorized into hospitals and clinics, home healthcare, and others.
  • On a regional basis, the market has been segmented into North America (the United States, and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Latin America (Brazil, Mexico, and Others), and Middle East and Africa.
  • The competitive landscape of the market has also been examined, with some of the key players being A. Menarini Diagnostics srl, Advancare Pharma, Arkray Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Hindustan Syringes & Medical Devices Ltd., HTL Strefa SA, Novo Nordisk A/S, Owen Mumford Ltd., Simple Diagnostics, Trividia Health Inc. (Sinocare), and Ultimed Inc.


Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Segment Coverage Type, Needle Length, Therapy, Mode of Purchase, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered A. Menarini Diagnostics srl, Advancare Pharma, Arkray Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Hindustan Syringes & Medical Devices Ltd., HTL Strefa SA, Novo Nordisk A/S, Owen Mumford Ltd., Simple Diagnostics, Trividia Health Inc. (Sinocare) and Ultimed Inc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter : @imarcglobal

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Pen Needles Market to Reach USD 11.8 Billion by 2033, Supported by the Increasing Prevalence of Lifestyle Diseases
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials